Head and Neck Cancer
SS 31 - H&N 3 - Strategies to Improve Outcomes and Minimize Toxicity in Oropharyngeal Cancer
Thomas Galloway, MD
Employment
Fox Chase Cancer Center: Attending Physician, Director of Clinical Research: Employee
Compensation
Varian: Speaker's Bureau
Ownership
UpToDate Inc: Royalty
Leadership
Rare Tumors Task Force: Co-Chair
Disclosure:
Employment
Fox Chase Cancer Center: Attending Physician, Director of Clinical Research: Employee
Compensation
Varian: Speaker's Bureau
Ownership
UpToDate Inc: Royalty
Leadership
Rare Tumors Task Force: Co-Chair
Tuesday, October 23
6:05 PM – 6:15 PM
The asset you are trying to access is locked. Please enter your access key to unlock.